Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage
We report 2 cases of primary central nervous system (CNS) lymphoma arising in the region of the optic nerve. For both patients, diagnosis of lymphoma was impossible without histological examination because of the rarity of the lymphoma location. The first case involved an 84-year-old woman who devel...
Gespeichert in:
Veröffentlicht in: | Brain tumor pathology 2014-07, Vol.31 (3), p.222-228 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 228 |
---|---|
container_issue | 3 |
container_start_page | 222 |
container_title | Brain tumor pathology |
container_volume | 31 |
creator | Matsuyama, Junko Ichikawa, Masahiro Oikawa, Tomoyoshi Sato, Taku Kishida, Yugo Oda, Keiko Maeda, Takuya Yamada, Masayuki Kuromi, Yosuke Matsumoto, Yuka Ando, Hitoshi Sakuma, Jun Saito, Kiyoshi |
description | We report 2 cases of primary central nervous system (CNS) lymphoma arising in the region of the optic nerve. For both patients, diagnosis of lymphoma was impossible without histological examination because of the rarity of the lymphoma location. The first case involved an 84-year-old woman who developed loss of vision and hypopituitarism. Intraoperative finding was optic glioma; histological diagnosis was diffuse large B cell lymphoma, however. The second case involved a 67-year-old man who developed loss of vision. The pre-surgical diagnosis was optic nerve neuritis; this was then revised to granuloma. The tumor arose in the optic nerve. Methotrexate and rituximab were administered and the patient remained in complete remission for 3 years. However, a sudden intratumoral hemorrhage occurred. Although most of the lymphoma cells obtained from the initial surgery were negative for vascular endothelial growth factor (VEGF) immunoreactivity, high levels of VEGF immunoreactivity in lymphoma cells was detected in the specimen obtained after intratumoral bleeding at recurrence, and correlation between VEGF reactivity and tumor recurrence was suggested. To date, primary CNS lymphomas with intracerebral hemorrhage have been reported in 3 cases only, and a correlation between intratumoral hemorrhage and the degree of VEGF expression has been suggested. VEGF also might have predictive significance for recurrence. |
doi_str_mv | 10.1007/s10014-013-0159-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1548638727</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1548638727</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-9e8f63b2289de6649cd06b56e8064fee1bf23bb9543322f98716c6e801df4de53</originalsourceid><addsrcrecordid>eNp1kduK1jAUhYMozjj6AN5IwBsvrObQ5uDd8OMJBhVU8C6k6e7fDG1Sk3ZknsjXNJ2OCoIXOWz2t1bCXgg9puQFJUS-zGWndUUoL6vRlbqDTqkStOJKfrtb7jXnleRanaAHOV8SUtdE0vvohHGttRTyFP38lPxk0zU-fPiMx-tpHuJksU0--3DEPuBlAJzg6GPAsb-p4rx4hwOkK8Bzggxh2Vib8Rhz3qiroo7hFWbY2bzJ55iW_LzYuXHtbmA828UXJf7hl6GUk83ZF0MflmQdJGiTHfEAU0xpsEd4iO71dszw6PY8Q1_fvP5yeFddfHz7_nB-UblaiKXSoHrBW8aU7kCIWruOiLYRoIioewDa9oy3rW7KZBjrtZJUuK1Lu77uoOFn6NnuO6f4fYW8mMlnB-NoA8Q1G9rUSpTxMlnQp_-gl3FNofzOME0VaSRTmyHdKZfKdBL0Zt4nbigxW4pmT9GUFM2WolFF8-TWeW0n6P4ofsdWALYDubTCEdLfp__v-gtHQKmc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2918057285</pqid></control><display><type>article</type><title>Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage</title><source>MEDLINE</source><source>ProQuest Central (Alumni Edition)</source><source>ProQuest Central UK/Ireland</source><source>SpringerLink Journals - AutoHoldings</source><source>ProQuest Central</source><creator>Matsuyama, Junko ; Ichikawa, Masahiro ; Oikawa, Tomoyoshi ; Sato, Taku ; Kishida, Yugo ; Oda, Keiko ; Maeda, Takuya ; Yamada, Masayuki ; Kuromi, Yosuke ; Matsumoto, Yuka ; Ando, Hitoshi ; Sakuma, Jun ; Saito, Kiyoshi</creator><creatorcontrib>Matsuyama, Junko ; Ichikawa, Masahiro ; Oikawa, Tomoyoshi ; Sato, Taku ; Kishida, Yugo ; Oda, Keiko ; Maeda, Takuya ; Yamada, Masayuki ; Kuromi, Yosuke ; Matsumoto, Yuka ; Ando, Hitoshi ; Sakuma, Jun ; Saito, Kiyoshi</creatorcontrib><description>We report 2 cases of primary central nervous system (CNS) lymphoma arising in the region of the optic nerve. For both patients, diagnosis of lymphoma was impossible without histological examination because of the rarity of the lymphoma location. The first case involved an 84-year-old woman who developed loss of vision and hypopituitarism. Intraoperative finding was optic glioma; histological diagnosis was diffuse large B cell lymphoma, however. The second case involved a 67-year-old man who developed loss of vision. The pre-surgical diagnosis was optic nerve neuritis; this was then revised to granuloma. The tumor arose in the optic nerve. Methotrexate and rituximab were administered and the patient remained in complete remission for 3 years. However, a sudden intratumoral hemorrhage occurred. Although most of the lymphoma cells obtained from the initial surgery were negative for vascular endothelial growth factor (VEGF) immunoreactivity, high levels of VEGF immunoreactivity in lymphoma cells was detected in the specimen obtained after intratumoral bleeding at recurrence, and correlation between VEGF reactivity and tumor recurrence was suggested. To date, primary CNS lymphomas with intracerebral hemorrhage have been reported in 3 cases only, and a correlation between intratumoral hemorrhage and the degree of VEGF expression has been suggested. VEGF also might have predictive significance for recurrence.</description><identifier>ISSN: 1433-7398</identifier><identifier>EISSN: 1861-387X</identifier><identifier>DOI: 10.1007/s10014-013-0159-8</identifier><identifier>PMID: 23999767</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Murine-Derived - administration & dosage ; Antineoplastic Combined Chemotherapy Protocols ; Biomarkers - metabolism ; Biopsy ; Blindness - etiology ; Cancer Research ; Case Report ; Case reports ; Cerebral Hemorrhage - diagnosis ; Cerebral Hemorrhage - etiology ; Chemotherapy ; Epstein-Barr virus ; Female ; Hematoma ; Hemorrhage ; Humans ; Hypopituitarism - etiology ; Lymphocytes ; Lymphoma ; Lymphoma, Large B-Cell, Diffuse - complications ; Lymphoma, Large B-Cell, Diffuse - drug therapy ; Lymphoma, Large B-Cell, Diffuse - pathology ; Lymphoma, Large B-Cell, Diffuse - surgery ; Magnetic resonance imaging ; Male ; Medical imaging ; Medicine ; Medicine & Public Health ; Methotrexate - administration & dosage ; Neoplasm Recurrence, Local ; Nervous system ; Neurology ; Neurosurgery ; Oncology ; Ophthalmology ; Optic nerve ; Optic Nerve Neoplasms - complications ; Optic Nerve Neoplasms - drug therapy ; Optic Nerve Neoplasms - pathology ; Optic Nerve Neoplasms - surgery ; Pathology ; Predictive Value of Tests ; Radiation therapy ; Remission Induction ; Rituximab ; Steroids ; Stroke ; Tomography ; Tumors ; Vascular endothelial growth factor ; Vascular Endothelial Growth Factor A - metabolism ; Visual acuity</subject><ispartof>Brain tumor pathology, 2014-07, Vol.31 (3), p.222-228</ispartof><rights>The Japan Society of Brain Tumor Pathology 2013</rights><rights>The Japan Society of Brain Tumor Pathology 2013.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-9e8f63b2289de6649cd06b56e8064fee1bf23bb9543322f98716c6e801df4de53</citedby><cites>FETCH-LOGICAL-c466t-9e8f63b2289de6649cd06b56e8064fee1bf23bb9543322f98716c6e801df4de53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10014-013-0159-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2918057285?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,21388,21389,27924,27925,33530,33531,33744,33745,41488,42557,43659,43805,51319,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23999767$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matsuyama, Junko</creatorcontrib><creatorcontrib>Ichikawa, Masahiro</creatorcontrib><creatorcontrib>Oikawa, Tomoyoshi</creatorcontrib><creatorcontrib>Sato, Taku</creatorcontrib><creatorcontrib>Kishida, Yugo</creatorcontrib><creatorcontrib>Oda, Keiko</creatorcontrib><creatorcontrib>Maeda, Takuya</creatorcontrib><creatorcontrib>Yamada, Masayuki</creatorcontrib><creatorcontrib>Kuromi, Yosuke</creatorcontrib><creatorcontrib>Matsumoto, Yuka</creatorcontrib><creatorcontrib>Ando, Hitoshi</creatorcontrib><creatorcontrib>Sakuma, Jun</creatorcontrib><creatorcontrib>Saito, Kiyoshi</creatorcontrib><title>Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage</title><title>Brain tumor pathology</title><addtitle>Brain Tumor Pathol</addtitle><addtitle>Brain Tumor Pathol</addtitle><description>We report 2 cases of primary central nervous system (CNS) lymphoma arising in the region of the optic nerve. For both patients, diagnosis of lymphoma was impossible without histological examination because of the rarity of the lymphoma location. The first case involved an 84-year-old woman who developed loss of vision and hypopituitarism. Intraoperative finding was optic glioma; histological diagnosis was diffuse large B cell lymphoma, however. The second case involved a 67-year-old man who developed loss of vision. The pre-surgical diagnosis was optic nerve neuritis; this was then revised to granuloma. The tumor arose in the optic nerve. Methotrexate and rituximab were administered and the patient remained in complete remission for 3 years. However, a sudden intratumoral hemorrhage occurred. Although most of the lymphoma cells obtained from the initial surgery were negative for vascular endothelial growth factor (VEGF) immunoreactivity, high levels of VEGF immunoreactivity in lymphoma cells was detected in the specimen obtained after intratumoral bleeding at recurrence, and correlation between VEGF reactivity and tumor recurrence was suggested. To date, primary CNS lymphomas with intracerebral hemorrhage have been reported in 3 cases only, and a correlation between intratumoral hemorrhage and the degree of VEGF expression has been suggested. VEGF also might have predictive significance for recurrence.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies, Monoclonal, Murine-Derived - administration & dosage</subject><subject>Antineoplastic Combined Chemotherapy Protocols</subject><subject>Biomarkers - metabolism</subject><subject>Biopsy</subject><subject>Blindness - etiology</subject><subject>Cancer Research</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Cerebral Hemorrhage - diagnosis</subject><subject>Cerebral Hemorrhage - etiology</subject><subject>Chemotherapy</subject><subject>Epstein-Barr virus</subject><subject>Female</subject><subject>Hematoma</subject><subject>Hemorrhage</subject><subject>Humans</subject><subject>Hypopituitarism - etiology</subject><subject>Lymphocytes</subject><subject>Lymphoma</subject><subject>Lymphoma, Large B-Cell, Diffuse - complications</subject><subject>Lymphoma, Large B-Cell, Diffuse - drug therapy</subject><subject>Lymphoma, Large B-Cell, Diffuse - pathology</subject><subject>Lymphoma, Large B-Cell, Diffuse - surgery</subject><subject>Magnetic resonance imaging</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Methotrexate - administration & dosage</subject><subject>Neoplasm Recurrence, Local</subject><subject>Nervous system</subject><subject>Neurology</subject><subject>Neurosurgery</subject><subject>Oncology</subject><subject>Ophthalmology</subject><subject>Optic nerve</subject><subject>Optic Nerve Neoplasms - complications</subject><subject>Optic Nerve Neoplasms - drug therapy</subject><subject>Optic Nerve Neoplasms - pathology</subject><subject>Optic Nerve Neoplasms - surgery</subject><subject>Pathology</subject><subject>Predictive Value of Tests</subject><subject>Radiation therapy</subject><subject>Remission Induction</subject><subject>Rituximab</subject><subject>Steroids</subject><subject>Stroke</subject><subject>Tomography</subject><subject>Tumors</subject><subject>Vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>Visual acuity</subject><issn>1433-7398</issn><issn>1861-387X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kduK1jAUhYMozjj6AN5IwBsvrObQ5uDd8OMJBhVU8C6k6e7fDG1Sk3ZknsjXNJ2OCoIXOWz2t1bCXgg9puQFJUS-zGWndUUoL6vRlbqDTqkStOJKfrtb7jXnleRanaAHOV8SUtdE0vvohHGttRTyFP38lPxk0zU-fPiMx-tpHuJksU0--3DEPuBlAJzg6GPAsb-p4rx4hwOkK8Bzggxh2Vib8Rhz3qiroo7hFWbY2bzJ55iW_LzYuXHtbmA828UXJf7hl6GUk83ZF0MflmQdJGiTHfEAU0xpsEd4iO71dszw6PY8Q1_fvP5yeFddfHz7_nB-UblaiKXSoHrBW8aU7kCIWruOiLYRoIioewDa9oy3rW7KZBjrtZJUuK1Lu77uoOFn6NnuO6f4fYW8mMlnB-NoA8Q1G9rUSpTxMlnQp_-gl3FNofzOME0VaSRTmyHdKZfKdBL0Zt4nbigxW4pmT9GUFM2WolFF8-TWeW0n6P4ofsdWALYDubTCEdLfp__v-gtHQKmc</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Matsuyama, Junko</creator><creator>Ichikawa, Masahiro</creator><creator>Oikawa, Tomoyoshi</creator><creator>Sato, Taku</creator><creator>Kishida, Yugo</creator><creator>Oda, Keiko</creator><creator>Maeda, Takuya</creator><creator>Yamada, Masayuki</creator><creator>Kuromi, Yosuke</creator><creator>Matsumoto, Yuka</creator><creator>Ando, Hitoshi</creator><creator>Sakuma, Jun</creator><creator>Saito, Kiyoshi</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>7X8</scope></search><sort><creationdate>20140701</creationdate><title>Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage</title><author>Matsuyama, Junko ; Ichikawa, Masahiro ; Oikawa, Tomoyoshi ; Sato, Taku ; Kishida, Yugo ; Oda, Keiko ; Maeda, Takuya ; Yamada, Masayuki ; Kuromi, Yosuke ; Matsumoto, Yuka ; Ando, Hitoshi ; Sakuma, Jun ; Saito, Kiyoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-9e8f63b2289de6649cd06b56e8064fee1bf23bb9543322f98716c6e801df4de53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies, Monoclonal, Murine-Derived - administration & dosage</topic><topic>Antineoplastic Combined Chemotherapy Protocols</topic><topic>Biomarkers - metabolism</topic><topic>Biopsy</topic><topic>Blindness - etiology</topic><topic>Cancer Research</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Cerebral Hemorrhage - diagnosis</topic><topic>Cerebral Hemorrhage - etiology</topic><topic>Chemotherapy</topic><topic>Epstein-Barr virus</topic><topic>Female</topic><topic>Hematoma</topic><topic>Hemorrhage</topic><topic>Humans</topic><topic>Hypopituitarism - etiology</topic><topic>Lymphocytes</topic><topic>Lymphoma</topic><topic>Lymphoma, Large B-Cell, Diffuse - complications</topic><topic>Lymphoma, Large B-Cell, Diffuse - drug therapy</topic><topic>Lymphoma, Large B-Cell, Diffuse - pathology</topic><topic>Lymphoma, Large B-Cell, Diffuse - surgery</topic><topic>Magnetic resonance imaging</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Methotrexate - administration & dosage</topic><topic>Neoplasm Recurrence, Local</topic><topic>Nervous system</topic><topic>Neurology</topic><topic>Neurosurgery</topic><topic>Oncology</topic><topic>Ophthalmology</topic><topic>Optic nerve</topic><topic>Optic Nerve Neoplasms - complications</topic><topic>Optic Nerve Neoplasms - drug therapy</topic><topic>Optic Nerve Neoplasms - pathology</topic><topic>Optic Nerve Neoplasms - surgery</topic><topic>Pathology</topic><topic>Predictive Value of Tests</topic><topic>Radiation therapy</topic><topic>Remission Induction</topic><topic>Rituximab</topic><topic>Steroids</topic><topic>Stroke</topic><topic>Tomography</topic><topic>Tumors</topic><topic>Vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>Visual acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsuyama, Junko</creatorcontrib><creatorcontrib>Ichikawa, Masahiro</creatorcontrib><creatorcontrib>Oikawa, Tomoyoshi</creatorcontrib><creatorcontrib>Sato, Taku</creatorcontrib><creatorcontrib>Kishida, Yugo</creatorcontrib><creatorcontrib>Oda, Keiko</creatorcontrib><creatorcontrib>Maeda, Takuya</creatorcontrib><creatorcontrib>Yamada, Masayuki</creatorcontrib><creatorcontrib>Kuromi, Yosuke</creatorcontrib><creatorcontrib>Matsumoto, Yuka</creatorcontrib><creatorcontrib>Ando, Hitoshi</creatorcontrib><creatorcontrib>Sakuma, Jun</creatorcontrib><creatorcontrib>Saito, Kiyoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><jtitle>Brain tumor pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsuyama, Junko</au><au>Ichikawa, Masahiro</au><au>Oikawa, Tomoyoshi</au><au>Sato, Taku</au><au>Kishida, Yugo</au><au>Oda, Keiko</au><au>Maeda, Takuya</au><au>Yamada, Masayuki</au><au>Kuromi, Yosuke</au><au>Matsumoto, Yuka</au><au>Ando, Hitoshi</au><au>Sakuma, Jun</au><au>Saito, Kiyoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage</atitle><jtitle>Brain tumor pathology</jtitle><stitle>Brain Tumor Pathol</stitle><addtitle>Brain Tumor Pathol</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>31</volume><issue>3</issue><spage>222</spage><epage>228</epage><pages>222-228</pages><issn>1433-7398</issn><eissn>1861-387X</eissn><abstract>We report 2 cases of primary central nervous system (CNS) lymphoma arising in the region of the optic nerve. For both patients, diagnosis of lymphoma was impossible without histological examination because of the rarity of the lymphoma location. The first case involved an 84-year-old woman who developed loss of vision and hypopituitarism. Intraoperative finding was optic glioma; histological diagnosis was diffuse large B cell lymphoma, however. The second case involved a 67-year-old man who developed loss of vision. The pre-surgical diagnosis was optic nerve neuritis; this was then revised to granuloma. The tumor arose in the optic nerve. Methotrexate and rituximab were administered and the patient remained in complete remission for 3 years. However, a sudden intratumoral hemorrhage occurred. Although most of the lymphoma cells obtained from the initial surgery were negative for vascular endothelial growth factor (VEGF) immunoreactivity, high levels of VEGF immunoreactivity in lymphoma cells was detected in the specimen obtained after intratumoral bleeding at recurrence, and correlation between VEGF reactivity and tumor recurrence was suggested. To date, primary CNS lymphomas with intracerebral hemorrhage have been reported in 3 cases only, and a correlation between intratumoral hemorrhage and the degree of VEGF expression has been suggested. VEGF also might have predictive significance for recurrence.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>23999767</pmid><doi>10.1007/s10014-013-0159-8</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1433-7398 |
ispartof | Brain tumor pathology, 2014-07, Vol.31 (3), p.222-228 |
issn | 1433-7398 1861-387X |
language | eng |
recordid | cdi_proquest_miscellaneous_1548638727 |
source | MEDLINE; ProQuest Central (Alumni Edition); ProQuest Central UK/Ireland; SpringerLink Journals - AutoHoldings; ProQuest Central |
subjects | Aged Aged, 80 and over Antibodies, Monoclonal, Murine-Derived - administration & dosage Antineoplastic Combined Chemotherapy Protocols Biomarkers - metabolism Biopsy Blindness - etiology Cancer Research Case Report Case reports Cerebral Hemorrhage - diagnosis Cerebral Hemorrhage - etiology Chemotherapy Epstein-Barr virus Female Hematoma Hemorrhage Humans Hypopituitarism - etiology Lymphocytes Lymphoma Lymphoma, Large B-Cell, Diffuse - complications Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - pathology Lymphoma, Large B-Cell, Diffuse - surgery Magnetic resonance imaging Male Medical imaging Medicine Medicine & Public Health Methotrexate - administration & dosage Neoplasm Recurrence, Local Nervous system Neurology Neurosurgery Oncology Ophthalmology Optic nerve Optic Nerve Neoplasms - complications Optic Nerve Neoplasms - drug therapy Optic Nerve Neoplasms - pathology Optic Nerve Neoplasms - surgery Pathology Predictive Value of Tests Radiation therapy Remission Induction Rituximab Steroids Stroke Tomography Tumors Vascular endothelial growth factor Vascular Endothelial Growth Factor A - metabolism Visual acuity |
title | Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T09%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20CNS%20lymphoma%20arising%20in%20the%20region%20of%20the%20optic%20nerve%20presenting%20as%20loss%20of%20vision:%202%20case%20reports,%20including%20a%20patient%20with%20a%20massive%20intracerebral%20hemorrhage&rft.jtitle=Brain%20tumor%20pathology&rft.au=Matsuyama,%20Junko&rft.date=2014-07-01&rft.volume=31&rft.issue=3&rft.spage=222&rft.epage=228&rft.pages=222-228&rft.issn=1433-7398&rft.eissn=1861-387X&rft_id=info:doi/10.1007/s10014-013-0159-8&rft_dat=%3Cproquest_cross%3E1548638727%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2918057285&rft_id=info:pmid/23999767&rfr_iscdi=true |